Japan relies almost entirely on China for the APIs of β-lactam antibiotics. These drugs are essential for treating infectious diseases…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS Top 100 Products in FY2011: Pronounced Growth for ARB Combinations with Declining Sales of Monodrugs
June 15, 2012
-
BUSINESS Sanofi, Hisamitsu to Form JV for Allergy-Related OTCs, Seen Eyeing Allegra OTC Launch
June 14, 2012
-
REGULATORY Ryukaikon’s Working Team Prepares to Start Operations by End of June; Beginning with Exchange of Opinions between JPWA, NPhA
June 13, 2012
-
BUSINESS Sawai Considers Leveraging “MSs with MR Qualifications” with Medipal Group
June 12, 2012
-
BUSINESS University of Tokyo Hospital to Take Over Development of Takeda’s AD Treatment Candidate
June 11, 2012
-
REGULATORY Expert Subcommittee Begins Discussions on Pricing of Long-Listed Drugs with Focus on Differences from Generic Prices
June 8, 2012
-
BUSINESS Mr Mark Swindell Appointed Head of Specialty Care: Pfizer Japan
June 7, 2012
-
ORGANIZATION JAPMS to Establish Working Group on Improvement of Drug Distribution
June 6, 2012
-
BUSINESS Volume Discounts Are Naturally Expected in Price Negotiations: President Otani of Ain Pharmaciez
June 5, 2012
-
REGULATORY DPJ’s Proposal on 5-Year Innovation Strategy Calls for Subsidies to Reduce Consultation, Review Fees
June 4, 2012
-
BUSINESS Ono Pharmaceutical to Collaborate with UK Company in Research of Drug Targets for Allergic Diseases
June 1, 2012
-
REGULATORY DPJ Proposal to Amend PAL Would Mandate Reporting of Package Inserts
May 31, 2012
-
BUSINESS Kyorin Holdings to Boost Manufacturing System with Transfer of MSD Plant
May 30, 2012
-
REGULATORY MHLW Sets Up Office for Promotion of Medical Innovation to Realize New 5-Year Strategy
May 29, 2012
-
BUSINESS Sanofi-aventis Applies for Switch OTC Allegra, PAFSC Committee to Review on June 7
May 28, 2012
-
REGULATORY DPJ’s PAL Subcommittee Calls for Mandatory Submission of Package Inserts
May 24, 2012
-
BUSINESS 11 Leading Foreign-Affiliated Drug Makers Report 12% Growth in Sales in 2011 Driven by New Drugs
May 23, 2012
-
BUSINESS Japan Vaccine to Make All-Out Effort,“Invest All Resources” in Cervical Cancer, Rotavirus Vaccines
May 22, 2012
-
BUSINESS Chugai to Make CNS Its Strategic Field; 3 Compounds in Pipeline: President Kosaka
May 21, 2012
-
ORGANIZATION “Cost-Effective Assessment Inhibits Innovation”: FPMAJ Chairman Naito
May 18, 2012
ページ
Your company’s employer brand is your reputation as an employer and is crucial in attracting top talent. Some reputations are just not good; they may or not be deserved. That is just the perception in the market. Years ago there…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s key reimbursement policy panel on December 25 approved an outline of the FY2025 drug price revision, finalizing plans to…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
A Japanese health ministry panel discussing the generic industry structure on May 22 put together a report in which it…
The Ministry of Health, Labor and Welfare (MHLW) posted the final report compiled by its pharmaceutical regulation panel on its website on April 24, providing cases of drugs that could be exempted from all-case post marketing surveillance (PMS).The MHLW plans…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…
The Japanese health ministry’s expert panel tasked to discuss comprehensive policies for the rapid and stable supply of pharmaceuticals generally…